According to the Centers for Disease Control and Prevention, approximately 37.3 million Americans have diabetes, while ...

Dihydropyridine calcium-channel-blockers (DCCBs), used to treat high blood pressure, could speed up the progression of kidney ...

Doctors say the medication is designed to support healthier long-term routines rather than replace them.

Brazil: A large network meta-analysis suggests that commonly used glucose-lowering therapies in type 2 diabetes may differ ...

Among 537 adults, average change from baseline in HbA1c concentration was -1.69% with retatrutide 4 mg, -1.86% with 9 mg, and ...

Insulin resistance is the driving force behind type 2 diabetes. One benefit of intermittent fasting is that it can force the ...

I don't eat sugar, or I consume it only once in a month. How can I get diabetes? Are you also a believer of this? Well, it's ...

Type 2 diabetes is a heterogeneous disease with multiple functional defects in which weight excess has a major role. The contribution of the gut has been increasingly emphasised in recent years, ...

Novo Nordisk today announced new real‑world evidence in adults with type 2 diabetes (T2D) treated with once‑weekly ...

In a Phase 2 study, the investigational once-weekly injectable zenagamtide demonstrated significant improvements in blood ...

New data highlight the potential benefits of using berobenatide, an investigational injectable glucagon-like peptide-1 receptor agonist (GLP-1 RA) across patient populations—including in individuals ...

A new long-term study details how a common deep-fried snack could increase the risk of type 2 diabetes. Here are the forms of ...